Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme

被引:37
作者
Jones, ME
Schmitz, FJ
Fluit, AC [1 ]
Acar, J
Gupta, R
Verhoef, J
机构
[1] Univ Utrecht Hosp, Eijkman Winkler Inst Clin Microbiol, Utrecht, Netherlands
[2] Hop St Joseph, Dept Clin Microbiol, F-75674 Paris, France
[3] Bristol Myers Squibb Co, Princeton, NJ USA
关键词
D O I
10.1007/s100960050308
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The SENTRY Antimicrobial Surveillance Programme was established to provide a coordinated, standardised, international surveillance on antimicrobial resistance. In one part of the programme, isolates from skin and soft tissue infections sent from 20 hospitals in 12 different European countries were investigated in the European coordinating centre. Of 1013 isolates, Staphylococcus aureus and Pseudomonas aeruginosa were the most significant species, constituting almost 50% of the referred isolates. Methicillin resistance in Staphylococcus aureus averaged 22% across Europe, only slightly less than that in isolates derived from blood. Less than 5% of the enterococcal isolates were resistant to vancomycin, Piperacillin/tazobactam was the most active penicillin-derived p-lactam compound against Pseudomonas aeruginosa, inhibiting 91.3% of the isolates, while ceftazidime and cefepime were the most active cephalosporins, inhibiting 85.8% and 80.3% of the isolates, respectively. Putative extended-spectrum beta-lactamase production was not detected in Escherichia coli and was found in only 5.1% of the Klebsiella pneumoniae isolates. In general, strains of the family Enterobacteriaceae remained mostly susceptible to carbapenems, cefepime, and amikacin.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 19 条
[1]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[2]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[3]   EPIDEMIOLOGY OF DRUG-RESISTANCE - IMPLICATIONS FOR A POSTANTIMICROBIAL ERA [J].
COHEN, ML .
SCIENCE, 1992, 257 (5073) :1050-1055
[4]   Drug therapy - Antimicrobial-drug resistance [J].
Gold, HS ;
Moellering, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1445-1453
[5]   Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].
Hiramatsu, K ;
Hanaki, H ;
Ino, T ;
Yabuta, K ;
Oguri, T ;
Tenover, FC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136
[6]   The new threats of Gram positive pathogens: Re-emergence of things past [J].
Howe, RA ;
Brown, NM ;
Spencer, RC .
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (06) :444-449
[7]   Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study) [J].
Jarlier, V ;
Fosse, T ;
Philippon, A .
INTENSIVE CARE MEDICINE, 1996, 22 (10) :1057-1065
[8]   Current susceptibilities of Staphylococci to glycopeptides determined as part of an international resistance surveillance programme [J].
Jones, ME ;
Jones, RN ;
Sader, H ;
Verhoef, J ;
Acar, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) :119-121
[9]   Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp from intensive care units in Europe [J].
Livermore, DM ;
Yuan, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (03) :409-424
[10]  
LORIAN V, 1995, INFECT CONT HOSP EP, V16, P638